Literature DB >> 6476207

Treatment of neurocysticercosis with flubendazole.

E Téllez-Girón, M C Ramos, L Dufour, M Montante, E Tellez, J Rodríguez, F Gómez Méndez, E Mireles.   

Abstract

Thirteen patients with neurocysticercosis were studied and treated with flubendazole. Diagnostic procedures included computerized tomography (CT) and enzyme-linked immunosorbent assay. In 12 cases treatment with the drug led to clinical improvement. CT showed that some cysts regressed in size, and in two patients they disappeared. The treatment also lowered the antibody levels. The drug was well tolerated and no allergic reaction or other side effects were observed.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6476207     DOI： 10.4269/ajtmh.1984.33.627

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  4 in total

1.  Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis. 2. Immunological and cytogenetic studies.

Authors:  A Flisser; D Gonzalez; A Plancarte; P Ostrosky; R Montero; A Stephano; D Correa
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

2.  Repositioning Flubendazole for Spinal Cord Injury.

Authors:  Chen Guang Yu; Vimala Bondada; Sarbani Ghoshal; Ranjana Singh; Christina K Pistilli; Kavi Dayaram; Hina Iqbal; Madison Sands; Kate L Davis; Subarrao Bondada; James W Geddes
Journal:  J Neurotrauma       Date:  2019-03-15       Impact factor: 5.269

3.  Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen.

Authors:  Martin Michaelis; Bishr Agha; Florian Rothweiler; Nadine Löschmann; Yvonne Voges; Michel Mittelbronn; Tatjana Starzetz; Patrick N Harter; Behnaz A Abhari; Simone Fulda; Frank Westermann; Kristoffer Riecken; Silvia Spek; Klaus Langer; Michael Wiese; Wilhelm G Dirks; Richard Zehner; Jaroslav Cinatl; Mark N Wass; Jindrich Cinatl
Journal:  Sci Rep       Date:  2015-02-03       Impact factor: 4.379

4.  Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis.

Authors:  Megan Truong; Leigh G Monahan; Dee A Carter; Ian G Charles
Journal:  PeerJ       Date:  2018-05-04       Impact factor: 2.984
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.